Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update

Exelixis (EXEL) PT Lowered to $27 at RBC Capital

May 1, 2024 6:30 AM EDT

RBC Capital analyst Kennen MacKay lowered the price target on Exelixis (NASDAQ: EXEL) to $27.00 (from $28.00) while maintaining a Outperform rating.

The analyst comments "Cabometyx sales were notably lighter than typical though 1Q softness is a trend (also in '22 & '23) and we... More

Exelixis (EXEL) Misses Q1 EPS by 6c, Misses on Revenue

April 30, 2024 4:14 PM EDT

Exelixis (NASDAQ: EXEL) reported Q1 EPS of $0.17, $0.06 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $425 million versus the consensus estimate of $456.83 million.

GUIDANCE:

Exelixis sees FY2024 revenue of $1.83-1.93 billion, versus the consensus of $1.91... More